AB
Anurag Bhatia
About Anurag Bhatia
Data last updated:
Anurag Bhatia is a Director at Biocell Pharmaceuticals Private Limited (since 2011) and Director at Biocordis Pharmaceuticals Private Limited (since 2011). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹4.78 Cr; the largest is Biocell Pharmaceuticals Private Limited at ₹3.81 Cr (FY 2025). Earlier, Anurag Bhatia was a Director at Biosync Pharmaceuticals Private Limited (2008–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Aug 2011 | 2011 | ₹3.81 Cr (FY 2025) | Active | |
| Director | 06 Sep 2011 | 2011 | ₹97.5 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2008 | 2008 | ₹5.38 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anurag Bhatia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepika Bhatia | 10961166 | Biocell Pharmaceuticals Private Limited , Biocordis Pharmaceuticals Private Limited | Director |
| Karam Singh Babra | 03612866 | Biocordis Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anurag Bhatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anurag Bhatia
Anurag Bhatia currently holds 2 directorships: Biocell Pharmaceuticals Private Limited (Director, since 29 Aug 2011, revenue ₹3.81 Cr (FY 2025)); Biocordis Pharmaceuticals Private Limited (Director, since 06 Sep 2011, revenue ₹97.5 Lakh (FY 2025)).
Anurag Bhatia was first appointed on 01 Dec 2008 as Director at Biosync Pharmaceuticals Private Limited. The most recent appointment on record is 06 Sep 2011 at Biocordis Pharmaceuticals Private Limited.
The 2 current companies of Anurag Bhatia that report revenue have a combined latest revenue of ₹4.78 Cr: Biocell Pharmaceuticals Private Limited ₹3.81 Cr (FY 2025); Biocordis Pharmaceuticals Private Limited ₹97.5 Lakh (FY 2025).
Anurag Bhatia held 1 earlier board appointment: Biosync Pharmaceuticals Private Limited (Director, 01 Dec 2008 to 24 Feb 2025).
The current boards of Anurag Bhatia's companies include Deepika Bhatia (Biocell Pharmaceuticals Private Limited), Karam Singh Babra (Biocordis Pharmaceuticals Private Limited).